TSP407-Open TG-GATEs - Toxicogenomic signatures after exposure to puromycin aminonucleoside in the rat


TSA3744-Open TG-GATEs - Toxicogenomic signatures of Liver after exposure to puromycin aminonucleoside (500 microM, 2 hours) in the rat


TSA3745-Open TG-GATEs - Toxicogenomic signatures of Liver after exposure to puromycin aminonucleoside (12 mg/kg, 4 day) in the rat


TSA3746-Open TG-GATEs - Toxicogenomic signatures of Liver after exposure to puromycin aminonucleoside (4 mg/kg, 4 day) in the rat


TSA3747-Open TG-GATEs - Toxicogenomic signatures of Liver after exposure to puromycin aminonucleoside (12 mg/kg, 6 hours) in the rat


TSA3748-Open TG-GATEs - Toxicogenomic signatures of Liver after exposure to puromycin aminonucleoside (12 mg/kg, 9 hours) in the rat


TSA3749-Open TG-GATEs - Toxicogenomic signatures of Liver after exposure to puromycin aminonucleoside (4 mg/kg, 29 day) in the rat


TSA3750-Open TG-GATEs - Toxicogenomic signatures of Liver after exposure to puromycin aminonucleoside (12 mg/kg, 29 day) in the rat


TSA3751-Open TG-GATEs - Toxicogenomic signatures of Liver after exposure to puromycin aminonucleoside (40 mg/kg, 8 day) in the rat


TSA3752-Open TG-GATEs - Toxicogenomic signatures of Liver after exposure to puromycin aminonucleoside (40 mg/kg, 9 hours) in the rat


TSA3753-Open TG-GATEs - Toxicogenomic signatures of Liver after exposure to puromycin aminonucleoside (2500 microM, 24 hours) in the rat


TSA3754-Open TG-GATEs - Toxicogenomic signatures of Liver after exposure to puromycin aminonucleoside (2500 microM, 8 hours) in the rat


TSA3755-Open TG-GATEs - Toxicogenomic signatures of Liver after exposure to puromycin aminonucleoside (40 mg/kg, 6 hours) in the rat


TSA3756-Open TG-GATEs - Toxicogenomic signatures of Liver after exposure to puromycin aminonucleoside (4 mg/kg, 15 day) in the rat


TSA3757-Open TG-GATEs - Toxicogenomic signatures of Liver after exposure to puromycin aminonucleoside (100 microM, 24 hours) in the rat


TSA3758-Open TG-GATEs - Toxicogenomic signatures of Liver after exposure to puromycin aminonucleoside (2500 microM, 2 hours) in the rat


TSA3759-Open TG-GATEs - Toxicogenomic signatures of Liver after exposure to puromycin aminonucleoside (12 mg/kg, 24 hours) in the rat


TSA3760-Open TG-GATEs - Toxicogenomic signatures of Liver after exposure to puromycin aminonucleoside (100 microM, 8 hours) in the rat


TSA3761-Open TG-GATEs - Toxicogenomic signatures of Liver after exposure to puromycin aminonucleoside (120 mg/kg, 3 hours) in the rat


TSA3762-Open TG-GATEs - Toxicogenomic signatures of Liver after exposure to puromycin aminonucleoside (120 mg/kg, 6 hours) in the rat


TSA3763-Open TG-GATEs - Toxicogenomic signatures of Liver after exposure to puromycin aminonucleoside (500 microM, 24 hours) in the rat


TSA3764-Open TG-GATEs - Toxicogenomic signatures of Liver after exposure to puromycin aminonucleoside (100 microM, 2 hours) in the rat


TSA3765-Open TG-GATEs - Toxicogenomic signatures of Liver after exposure to puromycin aminonucleoside (40 mg/kg, 3 hours) in the rat


TSA3766-Open TG-GATEs - Toxicogenomic signatures of Liver after exposure to puromycin aminonucleoside (12 mg/kg, 8 day) in the rat


TSA3767-Open TG-GATEs - Toxicogenomic signatures of Liver after exposure to puromycin aminonucleoside (40 mg/kg, 4 day) in the rat


TSA3768-Open TG-GATEs - Toxicogenomic signatures of Liver after exposure to puromycin aminonucleoside (120 mg/kg, 9 hours) in the rat


TSA3769-Open TG-GATEs - Toxicogenomic signatures of Liver after exposure to puromycin aminonucleoside (12 mg/kg, 15 day) in the rat


TSA3770-Open TG-GATEs - Toxicogenomic signatures of Liver after exposure to puromycin aminonucleoside (120 mg/kg, 24 hours) in the rat


TSA3771-Open TG-GATEs - Toxicogenomic signatures of Liver after exposure to puromycin aminonucleoside (40 mg/kg, 24 hours) in the rat


TSA3772-Open TG-GATEs - Toxicogenomic signatures of Liver after exposure to puromycin aminonucleoside (4 mg/kg, 8 day) in the rat


TSA3773-Open TG-GATEs - Toxicogenomic signatures of Liver after exposure to puromycin aminonucleoside (12 mg/kg, 3 hours) in the rat


TSA3774-Open TG-GATEs - Toxicogenomic signatures of Liver after exposure to puromycin aminonucleoside (500 microM, 8 hours) in the rat


TSA3775-Open TG-GATEs - Toxicogenomic signatures of Kidney after exposure to puromycin aminonucleoside (12 mg/kg, 4 day) in the rat


TSA3776-Open TG-GATEs - Toxicogenomic signatures of Kidney after exposure to puromycin aminonucleoside (4 mg/kg, 4 day) in the rat


TSA3777-Open TG-GATEs - Toxicogenomic signatures of Kidney after exposure to puromycin aminonucleoside (12 mg/kg, 6 hours) in the rat


TSA3778-Open TG-GATEs - Toxicogenomic signatures of Kidney after exposure to puromycin aminonucleoside (4 mg/kg, 8 day) in the rat


TSA3779-Open TG-GATEs - Toxicogenomic signatures of Kidney after exposure to puromycin aminonucleoside (12 mg/kg, 29 day) in the rat


TSA3780-Open TG-GATEs - Toxicogenomic signatures of Kidney after exposure to puromycin aminonucleoside (40 mg/kg, 9 hours) in the rat


TSA3781-Open TG-GATEs - Toxicogenomic signatures of Kidney after exposure to puromycin aminonucleoside (40 mg/kg, 8 day) in the rat


TSA3782-Open TG-GATEs - Toxicogenomic signatures of Kidney after exposure to puromycin aminonucleoside (12 mg/kg, 24 hours) in the rat


TSA3783-Open TG-GATEs - Toxicogenomic signatures of Kidney after exposure to puromycin aminonucleoside (40 mg/kg, 6 hours) in the rat


TSA3784-Open TG-GATEs - Toxicogenomic signatures of Kidney after exposure to puromycin aminonucleoside (4 mg/kg, 15 day) in the rat


TSA3785-Open TG-GATEs - Toxicogenomic signatures of Kidney after exposure to puromycin aminonucleoside (4 mg/kg, 29 day) in the rat


TSA3786-Open TG-GATEs - Toxicogenomic signatures of Kidney after exposure to puromycin aminonucleoside (120 mg/kg, 3 hours) in the rat


TSA3787-Open TG-GATEs - Toxicogenomic signatures of Kidney after exposure to puromycin aminonucleoside (120 mg/kg, 6 hours) in the rat


TSA3788-Open TG-GATEs - Toxicogenomic signatures of Kidney after exposure to puromycin aminonucleoside (40 mg/kg, 3 hours) in the rat


TSA3789-Open TG-GATEs - Toxicogenomic signatures of Kidney after exposure to puromycin aminonucleoside (12 mg/kg, 8 day) in the rat


TSA3790-Open TG-GATEs - Toxicogenomic signatures of Kidney after exposure to puromycin aminonucleoside (40 mg/kg, 4 day) in the rat


TSA3791-Open TG-GATEs - Toxicogenomic signatures of Kidney after exposure to puromycin aminonucleoside (120 mg/kg, 9 hours) in the rat


TSA3792-Open TG-GATEs - Toxicogenomic signatures of Kidney after exposure to puromycin aminonucleoside (12 mg/kg, 15 day) in the rat


TSA3793-Open TG-GATEs - Toxicogenomic signatures of Kidney after exposure to puromycin aminonucleoside (120 mg/kg, 24 hours) in the rat


TSA3794-Open TG-GATEs - Toxicogenomic signatures of Kidney after exposure to puromycin aminonucleoside (40 mg/kg, 24 hours) in the rat


TSA3795-Open TG-GATEs - Toxicogenomic signatures of Kidney after exposure to puromycin aminonucleoside (12 mg/kg, 9 hours) in the rat


TSA3796-Open TG-GATEs - Toxicogenomic signatures of Kidney after exposure to puromycin aminonucleoside (12 mg/kg, 3 hours) in the rat


TSF3744-3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine


1 subfactor(s)
TSF3745-3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine


1 subfactor(s)
TSF3746-3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine


1 subfactor(s)
TSF3747-3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine


1 subfactor(s)
TSF3748-3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine


1 subfactor(s)
TSF3749-3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine


1 subfactor(s)
TSF3750-3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine


1 subfactor(s)
TSF3751-3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine


1 subfactor(s)
TSF3752-3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine


1 subfactor(s)
TSF3753-3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine


1 subfactor(s)
TSF3754-3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine


1 subfactor(s)
TSF3755-3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine


1 subfactor(s)
TSF3756-3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine


1 subfactor(s)
TSF3757-3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine


1 subfactor(s)
TSF3758-3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine


1 subfactor(s)
TSF3759-3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine


1 subfactor(s)
TSF3760-3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine


1 subfactor(s)
TSF3761-3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine


1 subfactor(s)
TSF3762-3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine


1 subfactor(s)
TSF3763-3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine


1 subfactor(s)
TSF3764-3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine


1 subfactor(s)
TSF3765-3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine


1 subfactor(s)
TSF3766-3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine


1 subfactor(s)
TSF3767-3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine


1 subfactor(s)
TSF3768-3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine


1 subfactor(s)
TSF3769-3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine


1 subfactor(s)
TSF3770-3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine


1 subfactor(s)
TSF3771-3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine


1 subfactor(s)
TSF3772-3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine


1 subfactor(s)
TSF3773-3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine


1 subfactor(s)
TSF3774-3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine


1 subfactor(s)
TSF3775-3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine


1 subfactor(s)
TSF3776-3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine


1 subfactor(s)
TSF3777-3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine


1 subfactor(s)
TSF3778-3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine


1 subfactor(s)
TSF3779-3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine


1 subfactor(s)
TSF3780-3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine


1 subfactor(s)
TSF3781-3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine


1 subfactor(s)
TSF3782-3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine


1 subfactor(s)
TSF3783-3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine


1 subfactor(s)
TSF3784-3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine


1 subfactor(s)
TSF3785-3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine


1 subfactor(s)
TSF3786-3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine


1 subfactor(s)
TSF3787-3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine


1 subfactor(s)
TSF3788-3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine


1 subfactor(s)
TSF3789-3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine


1 subfactor(s)
TSF3790-3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine


1 subfactor(s)
TSF3791-3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine


1 subfactor(s)
TSF3792-3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine


1 subfactor(s)
TSF3793-3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine


1 subfactor(s)
TSF3794-3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine


1 subfactor(s)
TSF3795-3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine


1 subfactor(s)
TSF3796-3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine


1 subfactor(s)
TSS3744-Open TG-GATEs - Toxicogenomic signatures of Liver after exposure to puromycin aminonucleoside (500 microM, 2 hours) in the rat


TSS3745-Open TG-GATEs - Toxicogenomic signatures of Liver after exposure to puromycin aminonucleoside (12 mg/kg, 4 day) in the rat


TSS3746-Open TG-GATEs - Toxicogenomic signatures of Liver after exposure to puromycin aminonucleoside (4 mg/kg, 4 day) in the rat


TSS3747-Open TG-GATEs - Toxicogenomic signatures of Liver after exposure to puromycin aminonucleoside (12 mg/kg, 6 hours) in the rat


TSS3748-Open TG-GATEs - Toxicogenomic signatures of Liver after exposure to puromycin aminonucleoside (12 mg/kg, 9 hours) in the rat


TSS3749-Open TG-GATEs - Toxicogenomic signatures of Liver after exposure to puromycin aminonucleoside (4 mg/kg, 29 day) in the rat


TSS3750-Open TG-GATEs - Toxicogenomic signatures of Liver after exposure to puromycin aminonucleoside (12 mg/kg, 29 day) in the rat


TSS3751-Open TG-GATEs - Toxicogenomic signatures of Liver after exposure to puromycin aminonucleoside (40 mg/kg, 8 day) in the rat


TSS3752-Open TG-GATEs - Toxicogenomic signatures of Liver after exposure to puromycin aminonucleoside (40 mg/kg, 9 hours) in the rat


TSS3753-Open TG-GATEs - Toxicogenomic signatures of Liver after exposure to puromycin aminonucleoside (2500 microM, 24 hours) in the rat


TSS3754-Open TG-GATEs - Toxicogenomic signatures of Liver after exposure to puromycin aminonucleoside (2500 microM, 8 hours) in the rat


TSS3755-Open TG-GATEs - Toxicogenomic signatures of Liver after exposure to puromycin aminonucleoside (40 mg/kg, 6 hours) in the rat


TSS3756-Open TG-GATEs - Toxicogenomic signatures of Liver after exposure to puromycin aminonucleoside (4 mg/kg, 15 day) in the rat


TSS3757-Open TG-GATEs - Toxicogenomic signatures of Liver after exposure to puromycin aminonucleoside (100 microM, 24 hours) in the rat


TSS3758-Open TG-GATEs - Toxicogenomic signatures of Liver after exposure to puromycin aminonucleoside (2500 microM, 2 hours) in the rat


TSS3759-Open TG-GATEs - Toxicogenomic signatures of Liver after exposure to puromycin aminonucleoside (12 mg/kg, 24 hours) in the rat


TSS3760-Open TG-GATEs - Toxicogenomic signatures of Liver after exposure to puromycin aminonucleoside (100 microM, 8 hours) in the rat


TSS3761-Open TG-GATEs - Toxicogenomic signatures of Liver after exposure to puromycin aminonucleoside (120 mg/kg, 3 hours) in the rat


TSS3762-Open TG-GATEs - Toxicogenomic signatures of Liver after exposure to puromycin aminonucleoside (120 mg/kg, 6 hours) in the rat


TSS3763-Open TG-GATEs - Toxicogenomic signatures of Liver after exposure to puromycin aminonucleoside (500 microM, 24 hours) in the rat


TSS3764-Open TG-GATEs - Toxicogenomic signatures of Liver after exposure to puromycin aminonucleoside (100 microM, 2 hours) in the rat


TSS3765-Open TG-GATEs - Toxicogenomic signatures of Liver after exposure to puromycin aminonucleoside (40 mg/kg, 3 hours) in the rat


TSS3766-Open TG-GATEs - Toxicogenomic signatures of Liver after exposure to puromycin aminonucleoside (12 mg/kg, 8 day) in the rat


TSS3767-Open TG-GATEs - Toxicogenomic signatures of Liver after exposure to puromycin aminonucleoside (40 mg/kg, 4 day) in the rat


TSS3768-Open TG-GATEs - Toxicogenomic signatures of Liver after exposure to puromycin aminonucleoside (120 mg/kg, 9 hours) in the rat


TSS3769-Open TG-GATEs - Toxicogenomic signatures of Liver after exposure to puromycin aminonucleoside (12 mg/kg, 15 day) in the rat


TSS3770-Open TG-GATEs - Toxicogenomic signatures of Liver after exposure to puromycin aminonucleoside (120 mg/kg, 24 hours) in the rat


TSS3771-Open TG-GATEs - Toxicogenomic signatures of Liver after exposure to puromycin aminonucleoside (40 mg/kg, 24 hours) in the rat


TSS3772-Open TG-GATEs - Toxicogenomic signatures of Liver after exposure to puromycin aminonucleoside (4 mg/kg, 8 day) in the rat


TSS3773-Open TG-GATEs - Toxicogenomic signatures of Liver after exposure to puromycin aminonucleoside (12 mg/kg, 3 hours) in the rat


TSS3774-Open TG-GATEs - Toxicogenomic signatures of Liver after exposure to puromycin aminonucleoside (500 microM, 8 hours) in the rat


TSS3775-Open TG-GATEs - Toxicogenomic signatures of Kidney after exposure to puromycin aminonucleoside (12 mg/kg, 4 day) in the rat


TSS3776-Open TG-GATEs - Toxicogenomic signatures of Kidney after exposure to puromycin aminonucleoside (4 mg/kg, 4 day) in the rat


TSS3777-Open TG-GATEs - Toxicogenomic signatures of Kidney after exposure to puromycin aminonucleoside (12 mg/kg, 6 hours) in the rat


TSS3778-Open TG-GATEs - Toxicogenomic signatures of Kidney after exposure to puromycin aminonucleoside (4 mg/kg, 8 day) in the rat


TSS3779-Open TG-GATEs - Toxicogenomic signatures of Kidney after exposure to puromycin aminonucleoside (12 mg/kg, 29 day) in the rat


TSS3780-Open TG-GATEs - Toxicogenomic signatures of Kidney after exposure to puromycin aminonucleoside (40 mg/kg, 9 hours) in the rat


TSS3781-Open TG-GATEs - Toxicogenomic signatures of Kidney after exposure to puromycin aminonucleoside (40 mg/kg, 8 day) in the rat


TSS3782-Open TG-GATEs - Toxicogenomic signatures of Kidney after exposure to puromycin aminonucleoside (12 mg/kg, 24 hours) in the rat


TSS3783-Open TG-GATEs - Toxicogenomic signatures of Kidney after exposure to puromycin aminonucleoside (40 mg/kg, 6 hours) in the rat


TSS3784-Open TG-GATEs - Toxicogenomic signatures of Kidney after exposure to puromycin aminonucleoside (4 mg/kg, 15 day) in the rat


TSS3785-Open TG-GATEs - Toxicogenomic signatures of Kidney after exposure to puromycin aminonucleoside (4 mg/kg, 29 day) in the rat


TSS3786-Open TG-GATEs - Toxicogenomic signatures of Kidney after exposure to puromycin aminonucleoside (120 mg/kg, 3 hours) in the rat


TSS3787-Open TG-GATEs - Toxicogenomic signatures of Kidney after exposure to puromycin aminonucleoside (120 mg/kg, 6 hours) in the rat


TSS3788-Open TG-GATEs - Toxicogenomic signatures of Kidney after exposure to puromycin aminonucleoside (40 mg/kg, 3 hours) in the rat


TSS3789-Open TG-GATEs - Toxicogenomic signatures of Kidney after exposure to puromycin aminonucleoside (12 mg/kg, 8 day) in the rat


TSS3790-Open TG-GATEs - Toxicogenomic signatures of Kidney after exposure to puromycin aminonucleoside (40 mg/kg, 4 day) in the rat


TSS3791-Open TG-GATEs - Toxicogenomic signatures of Kidney after exposure to puromycin aminonucleoside (120 mg/kg, 9 hours) in the rat


TSS3792-Open TG-GATEs - Toxicogenomic signatures of Kidney after exposure to puromycin aminonucleoside (12 mg/kg, 15 day) in the rat


TSS3793-Open TG-GATEs - Toxicogenomic signatures of Kidney after exposure to puromycin aminonucleoside (120 mg/kg, 24 hours) in the rat


TSS3794-Open TG-GATEs - Toxicogenomic signatures of Kidney after exposure to puromycin aminonucleoside (40 mg/kg, 24 hours) in the rat


TSS3795-Open TG-GATEs - Toxicogenomic signatures of Kidney after exposure to puromycin aminonucleoside (12 mg/kg, 9 hours) in the rat


TSS3796-Open TG-GATEs - Toxicogenomic signatures of Kidney after exposure to puromycin aminonucleoside (12 mg/kg, 3 hours) in the rat



TSP407 - Open TG-GATEs - Toxicogenomic signatures after exposure to puromycin aminonucleoside in the rat Public


Open TG-GATEs is a public toxicogenomics database developed so that a wider community of researchers could utilize the fruits of TGP and TGP2 research. This database provides public access to data on 170 of the compounds catalogued in TG-GATEs. Data searching can be refined using either the name of a compound or the pathological findings by organ as the starting point. Gene expression data linked to phenotype data in pathology findings can also be downloaded as a CEL(*)file.

Interventional Experimental design


No experimental design provided

Results


No results provided